Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently ...

Canadian Journal of Public Health / Revue Canadienne de Santé Publique, Vol. 69, No. 1 (JANUARY/FEBRUARY 1978), pp. 49-50, 53 (3 pages) Tularemia is caused by Francisella tularensis, a small ...

The bacterium Francisella tularensis, the causative agent of tularemia, remains a subject of intense scientific investigation due to its complex epidemiology, diverse clinical manifestations, and ...

Cases of tularemia — a rare and sometimes fatal infectious disease that is also known commonly as “rabbit fever” — have risen in the US in recent years. Between 2011 and 2022, there’s been a 56 ...

Scientists are gaining an insider's look behind the notorious infectivity of Francisella tularensis. Also called rabbit fever, the disease doesn't seem to spread from person to person. Instead, people ...

Disease name: Tularemia, also known as "rabbit fever" or "deer fly fever" Affected populations: This disease is rare in the U.S. Between 2011 and 2022, 2,462 cases of tularemia were reported in 47 ...

According to the Centers for Disease Control (CDC), the bacterium Francisella tularensis is highly infectious, and can sicken a variety of animals including rabbits, rodents and humans. It is ...

Although rabbit fever is rare, understanding its symptoms and taking preventive steps can go a long way in protecting yourself and your loved ones. If you live in or frequently visit areas with a high ...

Please provide your email address to receive an email when new articles are posted on . Tularemia is a zoonotic disease caused by Francisella tularensis, an aerobic gram-negative coccobacillus.

In Germany, 41 cases of tularemia were reported in 2016. The infections are mainly due to direct contact with infected animals or with insect vectors like ticks and mosquitos. Because contaminated ...

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases ...

Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently ...